Suchergebnisse - "Gervasoni, Cristina"

PubPharm (14)

1

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients : a recall of basic pharmacology concepts

enthalten in: European journal of clinical pharmacology | 2021

von Cattaneo, D. | Corbellino, M. | Gervasoni, C.

CommentOn: Eur J Clin Pharmacol. 2021 Mar;77(3):389-397. - PMID 33048175

2

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection : A retrospective cohort study

enthalten in: Journal of medical virology | 2021

von Giacomelli, A. | Pagani, G. | Ridolfo, A. | +17

3

Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Gervasoni, C. | Meraviglia, P. | Riva, A. | +6

CommentIn: Clin Infect Dis. 2020 Nov 5;71(8):2023. - PMID 32459828

4

COVID-19 trials in Italy : A call for simplicity, top standards and global pooling

enthalten in: International journal of cardiology | 2020

von Maggioni, A. | Andreotti, F. | Gervasoni, C. | +1

5

Generics for the Treatment of Hepatitis C in Monoinfected and HIV-coinfected Patients : Pros and Cons

enthalten in: AIDS reviews | 2017

von Cattaneo, D. | Fossati, A. | Resnati, C. | +2

6

Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting

enthalten in: Clinical and experimental pharmacology & physiology | 2017

von Milazzo, L. | Gervasoni, C. | Falvella, F. | +7

7

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction

enthalten in: Therapeutic drug monitoring | 2016

von Cattaneo, D. | Riva, A. | Clementi, E. | +2

8

Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient

enthalten in: European journal of clinical pharmacology | 2016

von Cattaneo, D. | Sollima, S. | Charbe, N. | +3

9

Effect of hepatitis B and C clearance on atazanavir exposure

enthalten in: European journal of clinical pharmacology | 2015

von Gervasoni, C. | Cattaneo, D. | Micheli, V. | +2

10

Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy

enthalten in: European journal of clinical pharmacology | 2015

von Gervasoni, C. | Peri, A. | Cattaneo, D. | +3